413 related articles for article (PubMed ID: 27989734)
1. Systemic application of AAV vectors targeting GFAP-expressing astrocytes in Z-Q175-KI Huntington's disease mice.
Vagner T; Dvorzhak A; Wójtowicz AM; Harms C; Grantyn R
Mol Cell Neurosci; 2016 Dec; 77():76-86. PubMed ID: 27989734
[TBL] [Abstract][Full Text] [Related]
2. Functional Indicators of Glutamate Transport in Single Striatal Astrocytes and the Influence of Kir4.1 in Normal and Huntington Mice.
Dvorzhak A; Vagner T; Kirmse K; Grantyn R
J Neurosci; 2016 May; 36(18):4959-75. PubMed ID: 27147650
[TBL] [Abstract][Full Text] [Related]
3. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
Hammond SL; Leek AN; Richman EH; Tjalkens RB
PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
[TBL] [Abstract][Full Text] [Related]
4. Astrocyte-selective AAV gene therapy through the endogenous GFAP promoter results in robust transduction in the rat spinal cord following injury.
Griffin JM; Fackelmeier B; Fong DM; Mouravlev A; Young D; O'Carroll SJ
Gene Ther; 2019 May; 26(5):198-210. PubMed ID: 30962538
[TBL] [Abstract][Full Text] [Related]
5. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
[TBL] [Abstract][Full Text] [Related]
6. Specific gene expression in mouse cortical astrocytes is mediated by a 1740bp-GFAP promoter-driven combined adeno-associated virus 2/5/7/8/9.
Meng X; Yang F; Ouyang T; Liu B; Wu C; Jiang W
Neurosci Lett; 2015 Apr; 593():45-50. PubMed ID: 25778419
[TBL] [Abstract][Full Text] [Related]
7. Glial fibrillary acidic protein promoter determines transgene expression in satellite glial cells following intraganglionic adeno-associated virus delivery in adult rats.
Xiang H; Xu H; Fan F; Shin SM; Hogan QH; Yu H
J Neurosci Res; 2018 Mar; 96(3):436-448. PubMed ID: 28941260
[TBL] [Abstract][Full Text] [Related]
8. Molecular comparison of GLT1+ and ALDH1L1+ astrocytes in vivo in astroglial reporter mice.
Yang Y; Vidensky S; Jin L; Jie C; Lorenzini I; Frankl M; Rothstein JD
Glia; 2011 Feb; 59(2):200-7. PubMed ID: 21046559
[TBL] [Abstract][Full Text] [Related]
9. Glial promoter selectivity following AAV-delivery to the immature brain.
von Jonquieres G; Mersmann N; Klugmann CB; Harasta AE; Lutz B; Teahan O; Housley GD; Fröhlich D; Krämer-Albers EM; Klugmann M
PLoS One; 2013; 8(6):e65646. PubMed ID: 23799030
[TBL] [Abstract][Full Text] [Related]
10. Regulation of astrocyte glutamate transporter-1 (GLT1) and aquaporin-4 (AQP4) expression in a model of epilepsy.
Hubbard JA; Szu JI; Yonan JM; Binder DK
Exp Neurol; 2016 Sep; 283(Pt A):85-96. PubMed ID: 27155358
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of glial progenitors that overexpress glutamate transporter GLT1 preserves diaphragm function following cervical SCI.
Li K; Javed E; Hala TJ; Sannie D; Regan KA; Maragakis NJ; Wright MC; Poulsen DJ; Lepore AC
Mol Ther; 2015 Mar; 23(3):533-48. PubMed ID: 25492561
[TBL] [Abstract][Full Text] [Related]
12. Microglial proliferation and astrocytic protein alterations in the human Huntington's disease cortex.
Tan AYS; Tippett LJ; Turner CP; Swanson MEV; Park TIH; Curtis MA; Faull RLM; Dragunow M; Singh-Bains MK
Neurobiol Dis; 2024 Aug; 198():106554. PubMed ID: 38844243
[TBL] [Abstract][Full Text] [Related]
13. Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector.
Rincon MY; de Vin F; Duqué SI; Fripont S; Castaldo SA; Bouhuijzen-Wenger J; Holt MG
Gene Ther; 2018 Apr; 25(2):83-92. PubMed ID: 29523880
[TBL] [Abstract][Full Text] [Related]
14. Spatial and temporal changes in promoter activity of the astrocyte glutamate transporter GLT1 following traumatic spinal cord injury.
Lepore AC; O'Donnell J; Bonner JF; Paul C; Miller ME; Rauck B; Kushner RA; Rothstein JD; Fischer I; Maragakis NJ
J Neurosci Res; 2011 Jul; 89(7):1001-17. PubMed ID: 21488085
[TBL] [Abstract][Full Text] [Related]
15. Dysfunctional Calcium and Glutamate Signaling in Striatal Astrocytes from Huntington's Disease Model Mice.
Jiang R; Diaz-Castro B; Looger LL; Khakh BS
J Neurosci; 2016 Mar; 36(12):3453-70. PubMed ID: 27013675
[TBL] [Abstract][Full Text] [Related]
16. Focused ultrasound as a novel strategy for noninvasive gene delivery to retinal Müller glia.
Touahri Y; Dixit R; Kofoed RH; Miloska K; Park E; Raeisossadati R; Markham-Coultes K; David LA; Rijal H; Zhao J; Lynch M; Hynynen K; Aubert I; Schuurmans C
Theranostics; 2020; 10(7):2982-2999. PubMed ID: 32194850
[TBL] [Abstract][Full Text] [Related]
17. AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease.
Franich NR; Fitzsimons HL; Fong DM; Klugmann M; During MJ; Young D
Mol Ther; 2008 May; 16(5):947-56. PubMed ID: 18388917
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse.
Miller BR; Dorner JL; Shou M; Sari Y; Barton SJ; Sengelaub DR; Kennedy RT; Rebec GV
Neuroscience; 2008 Apr; 153(1):329-37. PubMed ID: 18353560
[TBL] [Abstract][Full Text] [Related]
19. Generation of GFAP::GFP astrocyte reporter lines from human adult fibroblast-derived iPS cells using zinc-finger nuclease technology.
Zhang PW; Haidet-Phillips AM; Pham JT; Lee Y; Huo Y; Tienari PJ; Maragakis NJ; Sattler R; Rothstein JD
Glia; 2016 Jan; 64(1):63-75. PubMed ID: 26295203
[TBL] [Abstract][Full Text] [Related]
20. Cellular Analysis of Silencing the Huntington's Disease Gene Using AAV9 Mediated Delivery of Artificial Micro RNA into the Striatum of Q140/Q140 Mice.
Keeler AM; Sapp E; Chase K; Sottosanti E; Danielson E; Pfister E; Stoica L; DiFiglia M; Aronin N; Sena-Esteves M
J Huntingtons Dis; 2016 Oct; 5(3):239-248. PubMed ID: 27689620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
